A question and answer session with the recently appointed CEO of Kedrion, Val Romberg: his first impressions of the company, his views on growth potential, and his reflections on Kedrion’s commitment to developing new anti COVID-19 therapies.
You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
